Jupiter Neurosciences, Inc. SEC filings JUNS
Jupiter Neurosciences, Inc. has 203 filings in SEC EDGAR's recent list, going back to Jul 15, 2016. Its latest annual report, Form ARS, was filed on Jun 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Sep 4, 2026 | — |
| EFFECT | Filing | Jul 7, 2026 | — |
| EFFECT | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2026 | — |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Dec 11, 2025 | — |
| CORRESP | Letter to the SEC | Dec 9, 2025 | — |
| PRER14A | Filing | Oct 28, 2025 | — |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| CERT | Filing | Dec 2, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2024 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2023 | — |
| CORRESP | Letter to the SEC | Dec 7, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| CORRESP | Letter to the SEC | Sep 16, 2022 | — |
| CORRESP | Letter to the SEC | Sep 16, 2022 | — |
| CORRESP | Letter to the SEC | Sep 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 26, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2022 | — |
| 8-A12B/A | Filing | Aug 24, 2022 | — |
| CORRESP | Letter to the SEC | May 5, 2022 | — |
| UPLOAD | Letter from the SEC | May 4, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| UPLOAD | Letter from the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | Feb 14, 2022 | — |
| CORRESP | Letter to the SEC | Feb 14, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 8, 2022 | — |
| CORRESP | Letter to the SEC | Feb 8, 2022 | — |
| CORRESP | Letter to the SEC | Feb 8, 2022 | — |
| CORRESP | Letter to the SEC | Feb 8, 2022 | — |
| CERT | Filing | Feb 4, 2022 | — |
| 8-A12B | Filing | Feb 4, 2022 | — |
| CORRESP | Letter to the SEC | Feb 3, 2022 | — |
| CORRESP | Letter to the SEC | Feb 3, 2022 | — |
| CORRESP | Letter to the SEC | Feb 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2021 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| CORRESP | Letter to the SEC | Nov 9, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| DRS | Filing | Oct 1, 2021 | — |
| D | Filing | Dec 5, 2017 | — |
| D | Filing | Dec 28, 2016 | — |
| D | Filing | Jul 15, 2016 | — |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JUNS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jupiter, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1679628
- Former names
- Jupiter Orphan Therapeutics, Inc. (until Dec 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.